Cytotoxic effects of chemokine receptor 4 inhibition by AMD3100 in biliary tract cancer cells: Potential drug synergism with gemcitabine.

Christian Reinhard Mayr; Daniel Neureiter; Martin Pichler; Frieder Berr; Andrej Wagner; Tobias Kiesslich; Konrad Namberger

doi:10.3892/mmr.2015.3589

Cytotoxic effects of chemokine receptor 4 inhibition by AMD3100 in biliary tract cancer cells: Potential drug synergism with gemcitabine.

Christian Reinhard Mayr (First author)
, Daniel Neureiter (Co-author)
, Martin Pichler
, Frieder Berr (Co-author)
, Andrej Wagner (Co-author)
, Tobias Kiesslich^* (Co-author)
, Konrad Namberger

^*Corresponding author for this work

Research output: Contribution to journal › Original Article › peer-review

8 Citations (Web of Science)

Original language	English
Pages (from-to)	2247-2252
Journal	Molecular Medicine Reports
Volume	12
Issue number	2
DOIs	https://doi.org/10.3892/mmr.2015.3589
Publication status	Published - 2015

Keywords

HEPATIC STELLATE CELLS
BREAST-CANCER
CHOLANGIOCARCINOMA CELLS
STEM-CELLS
FACTOR-I
CXCR4
AXIS
METASTASIS
CARCINOMA
EXPRESSION

Access to Document

10.3892/mmr.2015.3589

A-12/02/006-KIE: ldentification of Novel Cancer Stem Cell-Related Drug Targets in Human Biliary Tract Cancer
Kiesslich, T. (PI) & Mayr, C. R. (Further contributor)
13/11/12 → 13/03/14
Project: Research
Identification of Novel Cancer Stem Cell‐Related Drug Targets in Human Biliary Tract Cancer
Kiesslich, T. (PI)
1/09/12 → 1/09/15
Project: Research

Cite this

@article{2981a63db16e4177859660a4970eccdc,

title = "Cytotoxic effects of chemokine receptor 4 inhibition by AMD3100 in biliary tract cancer cells: Potential drug synergism with gemcitabine.",

keywords = "HEPATIC STELLATE CELLS, BREAST-CANCER, CHOLANGIOCARCINOMA CELLS, STEM-CELLS, FACTOR-I, CXCR4, AXIS, METASTASIS, CARCINOMA, EXPRESSION",

author = "Mayr, \{Christian Reinhard\} and Daniel Neureiter and Martin Pichler and Frieder Berr and Andrej Wagner and Tobias Kiesslich and Konrad Namberger",

year = "2015",

doi = "10.3892/mmr.2015.3589",

language = "English",

volume = "12",

pages = "2247--2252",

journal = "Molecular Medicine Reports",

issn = "1791-2997",

number = "2",

}

Cytotoxic effects of chemokine receptor 4 inhibition by AMD3100 in biliary tract cancer cells: Potential drug synergism with gemcitabine. / Mayr, Christian Reinhard (First author); Neureiter, Daniel (Co-author); Pichler, Martin et al.
In: Molecular Medicine Reports, Vol. 12, No. 2, 2015, p. 2247-2252.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Cytotoxic effects of chemokine receptor 4 inhibition by AMD3100 in biliary tract cancer cells: Potential drug synergism with gemcitabine.

AU - Mayr, Christian Reinhard

AU - Neureiter, Daniel

AU - Pichler, Martin

AU - Berr, Frieder

AU - Wagner, Andrej

AU - Kiesslich, Tobias

AU - Namberger, Konrad

PY - 2015

Y1 - 2015

KW - HEPATIC STELLATE CELLS

KW - BREAST-CANCER

KW - CHOLANGIOCARCINOMA CELLS

KW - STEM-CELLS

KW - FACTOR-I

KW - CXCR4

KW - AXIS

KW - METASTASIS

KW - CARCINOMA

KW - EXPRESSION

U2 - 10.3892/mmr.2015.3589

DO - 10.3892/mmr.2015.3589

M3 - Original Article

C2 - 25846744

SN - 1791-2997

VL - 12

SP - 2247

EP - 2252

JO - Molecular Medicine Reports

JF - Molecular Medicine Reports

IS - 2

ER -

Cytotoxic effects of chemokine receptor 4 inhibition by AMD3100 in biliary tract cancer cells: Potential drug synergism with gemcitabine.

Keywords

Access to Document

Projects

A-12/02/006-KIE: ldentification of Novel Cancer Stem Cell-Related Drug Targets in Human Biliary Tract Cancer

Identification of Novel Cancer Stem Cell‐Related Drug Targets in Human Biliary Tract Cancer

Cite this